NCT07160829Completed
Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure Management
Source: ClinicalTrials.gov · Last updated 11 Feb 2026
Brief summary (registry, in English)
This is a survey-based study conducted among cardiologists and nephrologists treating people with Atherosclerotic Cardiovascular Disease (ASCVD), Heart Failure (HF) and Chronic Kidney Disease (CKD). Study participants will be recruited to complete self-administered online survey. The purpose of this research is to gather real-world evidence related to attitudes around systemic inflammation and specifically the awareness, perception, drivers and barriers, and use of hsCRP in clinical practice to identify systemic inflammation in people with ASCVD+CKD and HF.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 608 (actual)
- First submitted
- 29 Aug 2025
- Start date
- 18 Sept 2025
- Primary completion date
- 30 Oct 2025
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Chronic kidney disease, Heart failure
- NCT number
- NCT07160829
What you commit to
- Study type: Observational
- Participants enrolled: 608
- From 18 Sept 2025 to the primary completion date, 30 Oct 2025
- 4 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous participation in this study. Participation is defined as having given informed consent in this study.
Other
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
- If nephrologist, is only using dialysis to treat people with ASCVD and CKD.
- Does not meet inclusion criteria requirements.
Who the study is looking for
- Informed consent obtained before any study related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male or female, age above 18 years at the time of signing informed consent.
- Is a nephrologist or cardiologist. Cardiologists may be a mix of Interventional Cardiology, Heart Failure (HF) Specialist, General Cardiology, Preventative Cardiology, Cardiac Electrophysiology, Cardio-Oncology or Echocardiography (India only).
- Has been in specialty practice greater than or equal to 3 years.
- If cardiologist, sees at least 15 people with Atherosclerotic Cardiovascular Disease (ASCVD) with or without Chronic Kidney Disease (CKD) per month.
- If nephrologist, sees at least 20 people with ASCVD and CKD per month.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Sydney | Australia | Unknown status |
| - Coordinator of this site? Confirm its status | Bangalore | India | Unknown status |
| - Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| - Coordinator of this site? Confirm its status | Bangkok | Thailand | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.